These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9449042)

  • 21. beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
    Goel HL; Breen M; Zhang J; Das I; Aznavoorian-Cheshire S; Greenberg NM; Elgavish A; Languino LR
    Cancer Res; 2005 Aug; 65(15):6692-700. PubMed ID: 16061650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.
    Morrison KB; Tognon CE; Garnett MJ; Deal C; Sorensen PH
    Oncogene; 2002 Aug; 21(37):5684-95. PubMed ID: 12173038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail.
    Kim HJ; Litzenburger BC; Cui X; Delgado DA; Grabiner BC; Lin X; Lewis MT; Gottardis MM; Wong TW; Attar RM; Carboni JM; Lee AV
    Mol Cell Biol; 2007 Apr; 27(8):3165-75. PubMed ID: 17296734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Safety of insulin analogues: what to evaluate, how to do it, and how to interpret the results].
    Hernández Mijares A; Solá Izquierdo E; García Malpartida K; Verge D
    Endocrinol Nutr; 2010 Oct; 57(8):376-80. PubMed ID: 20621572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo antitumor activity and induction of insulin-like growth factor-1-resistant apoptosis by SC-alphaalphadelta9.
    Vogt A; Wang AS; Johnson CS; Fabisiak JP; Wipf P; Lazo JS
    J Pharmacol Exp Ther; 2000 Feb; 292(2):530-7. PubMed ID: 10640289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progression.
    Mauro L; Salerno M; Morelli C; Boterberg T; Bracke ME; Surmacz E
    J Cell Physiol; 2003 Feb; 194(2):108-16. PubMed ID: 12494449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis.
    Franks SE; Briah R; Jones RA; Moorehead RA
    Oncotarget; 2016 Jan; 7(3):3297-316. PubMed ID: 26654940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The IGF-I receptor in cancer research.
    Baserga R
    Exp Cell Res; 1999 Nov; 253(1):1-6. PubMed ID: 10579905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the IGF system in cancer growth and metastasis: overview and recent insights.
    Samani AA; Yakar S; LeRoith D; Brodt P
    Endocr Rev; 2007 Feb; 28(1):20-47. PubMed ID: 16931767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The contradictions of the insulin-like growth factor 1 receptor.
    Baserga R
    Oncogene; 2000 Nov; 19(49):5574-81. PubMed ID: 11114737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The IGF-I receptor: a new antiproliferative marker?].
    Fehmann HC; Staats P; Göke B
    Z Gastroenterol; 1995 Oct; 33(10):630-1. PubMed ID: 7502562
    [No Abstract]   [Full Text] [Related]  

  • 32. Targeting the insulin-like growth factor receptor-1R pathway for cancer therapy.
    Zha J; Lackner MR
    Clin Cancer Res; 2010 May; 16(9):2512-7. PubMed ID: 20388853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant IGF-I receptors as dominant negatives for growth and transformation.
    Burgaud JL; Resnicoff M; Baserga R
    Biochem Biophys Res Commun; 1995 Sep; 214(2):475-81. PubMed ID: 7677754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor.
    DeAngelis T; Ferber A; Baserga R
    J Cell Physiol; 1995 Jul; 164(1):214-21. PubMed ID: 7790393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
    Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
    Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The double life of the IGF-1 receptor.
    Baserga R
    Receptor; 1992; 2(4):261-6. PubMed ID: 1299412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Insulin, IGF-I and cancer].
    Ogawa W
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():552-5. PubMed ID: 23156457
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin-like growth factor 1 receptor activates c-SRC and modifies transformation and motility of colon cancer in vitro.
    Sekharam M; Nasir A; Kaiser HE; Coppola D
    Anticancer Res; 2003; 23(2B):1517-24. PubMed ID: 12820418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation.
    Tognon CE; Martin MJ; Moradian A; Trigo G; Rotblat B; Cheng SW; Pollard M; Uy E; Chow C; Carboni JM; Gottardis MM; Pollak M; Morin GB; Sorensen PH
    Oncogene; 2012 Mar; 31(10):1334-40. PubMed ID: 21804605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the IGF-1 receptor: from rags to riches.
    Baserga R
    Eur J Cancer; 2004 Sep; 40(14):2013-5. PubMed ID: 15341972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.